The evolution of SARS-CoV-2

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286

EVOLUTION IN MENDELIAN POPULATIONS

Wright, S. (1931) · Genetics · doi:10.1093/genetics/16.2.97 · Cited by 9,237

Virological assessment of hospitalized patients with COVID-2019

Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661

Origin and evolution of pathogenic coronaviruses

Cui, J., Li, F., & Shi, Z. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0118-9 · Cited by 5,729

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281

Coronaviruses: An Overview of Their Replication and Pathogenesis

Fehr, A. R., & Perlman, S. M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,910

Structural basis of receptor recognition by SARS-CoV-2

Shang, J., Ye, G., Shi, K., Wan, Y., Luo, C., Aihara, H., Geng, Q., Auerbach, A., & Li, F. (2020) · Nature · doi:10.1038/s41586-020-2179-y · Cited by 3,661

SARS-CoV-2 variants, spike mutations and immune escape

Harvey, W. T., Carabelli, A. M., Jackson, B., Gupta, R. K., Thomson, E. C., Harrison, E. M., Ludden, C., Reeve, R., Rambaut, A., COVID-19 Genomics UK (COG-UK) Consortium, et al. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00573-0 · Cited by 3,528

Nextstrain: real-time tracking of pathogen evolutionPreprint

Hadfield, J., Megill, C., Bell, S. M., et al. (2017) · bioRxiv · doi:10.1101/224048 · Cited by 3,172

Nextstrain: real-time tracking of pathogen evolution

Hadfield, J., Megill, C., Bell, S. M., Huddleston, J., Potter, B., Callender, C., Sagulenko, P., Bedford, T., & Neher, R. A. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty407 · Cited by 3,154

A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes

Sanderson, T., Hisner, R., Donovan-Banfield, I., Hartman, H. B., Løchen, A., Peacock, T. P., & Ruis, C. (2023) · Nature · doi:10.1038/s41586-023-06649-6 · Cited by 219

Implications of diversity in sperm size and function for sperm competition and fertility

Gomendio, M., & Roldán, E. R. S. (2008) · The International Journal of Developmental Biology · doi:10.1387/ijdb.082595mg · Cited by 187

Persistent SARS-CoV-2 infection: significance and implications

Machkovech, H. M., Hahn, A. M., Garonzik‐Wang, J., Grubaugh, N. D., Halfmann, P., Johnson, M. C., Lemieux, J. E., O’Connor, D. H., Piantadosi, A. L., Wei, W., et al. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(23)00815-0 · Cited by 161

spa typing of methicillin-resistant Staphylococcus aureus isolated from domestic animals and veterinary staff in the UK and Ireland

Moodley, A., Stegger, M., BAĞCIGİL, A. F., Baptiste, K. E., Loeffler, A., Lloyd, D. H., Williams, N. J., Leonard, N., Abbott, Y., Skov, R. L., et al. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl394 · Cited by 146

Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients

Feys, S., Carvalho, A., Clancy, C. J., Gangneux, J., Hoenigl, M., Lagrou, K., Rijnders, B. J. A., Seldeslachts, L., Vanderbeke, L., van de Veerdonk, F. L., et al. (2024) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(24)00151-6 · Cited by 140

SARS-CoV-2 evolution in the Omicron era

Roemer, C., Sheward, D. J., Hisner, R., Gueli, F., Sakaguchi, H., Frohberg, N., Schoenmakers, J., Sato, K., O’Toole, Á., Rambaut, A., et al. (2023) · Nature Microbiology · doi:10.1038/s41564-023-01504-w · Cited by 130

Fitness effects of mutations to SARS-CoV-2 proteins

Bloom, J. D., & Neher, R. A. (2023) · Virus Evolution · doi:10.1093/ve/vead055 · Cited by 131

Convergent evolution of SARS-CoV-2 XBB lineages on receptor-binding domain 455–456 synergistically enhances antibody evasion and ACE2 binding

Jian, F., Feng, L., Yang, S., Yu, Y., Wang, L., Song, W., Yisimayi, A., Chen, X., Xu, Y., Wang, P., et al. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011868 · Cited by 124

Comprehensive Review of COVID-19: Epidemiology, Pathogenesis, Advancement in Diagnostic and Detection Techniques, and Post-Pandemic Treatment Strategies

Chung, Y.-S., Lam, C.-Y., Tan, P.-H., Tsang, H. F., & Wong, S. C. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158155 · Cited by 120

B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity

Lapuente, D., Winkler, T., & Tenbusch, M. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01095-w · Cited by 101

Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults

Surie, D., Yuengling, K. A., DeCuir, J., Zhu, Y., Lauring, A. S., Gaglani, M., Ghamande, S. A., Peltan, I. D., Brown, S. M., Ginde, A. A., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.4954 · Cited by 90

SARS-CoV-2 and innate immunity: the good, the bad, and the “goldilocks”

Sievers, B. L., Cheng, M. T. K., Csiba, K., Meng, B., & Gupta, R. K. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01104-y · Cited by 91

SARS-CoV-2 evolution on a dynamic immune landscape

Raharinirina, N. A., Gubela, N., Börnigen, D., Smith, M. R., Oh, D., Budt, M., Mache, C., Schillings, C., Fuchs, S., Dürrwald, R., et al. (2025) · Nature · doi:10.1038/s41586-024-08477-8 · Cited by 88

Inhibitors of SARS-CoV-2 Main Protease (Mpro) as Anti-Coronavirus Agents

Zagórska, A., Czopek, A., Fryc, M., & Jończyk, J. (2024) · Biomolecules · doi:10.3390/biom14070797 · Cited by 74

Proactive vaccination using multiviral Quartet Nanocages to elicit broad anti-coronavirus responses

Hills, R. A., Tan, T. K., Cohen, A. A., Keeffe, J. R., Keeble, A. H., Gnanapragasam, P. N. P., Storm, K. N., Rorick, A. V., West, A. P., Hill, M. L., et al. (2024) · Nature Nanotechnology · doi:10.1038/s41565-024-01655-9 · Cited by 82

Genomic Tools in Biological Invasions: Current State and Future Frontiers

McGaughran, A., Dhami, M. K., Parvizi, E., Vaughan, A. L., Gleeson, D. M., Hodgins, K. A., Rollins, L. A., Tepolt, C. K., Turner, K. G., Atsawawaranunt, K., et al. (2023) · Genome Biology and Evolution · doi:10.1093/gbe/evad230 · Cited by 66

Interface‐Engineered Field‐Effect Transistor Electronic Devices for Biosensing

Zhang, Y., Chen, D., Wang, H., Chen, N., Zhou, L., Yu, L., Yang, Y., & Yuan, Q. (2023) · Advanced Materials · doi:10.1002/adma.202306252 · Cited by 63

Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron

Chemaitelly, H. S., Ayoub, H. H., Coyle, P. V., Tang, P., Hasan, M. R., Yassine, H. M., Thani, A. A. A., Kanaani, Z. A., Al‐Kuwari, E., Jeremijenko, A. M., et al. (2025) · Nature · doi:10.1038/s41586-024-08511-9 · Cited by 61

Vaccines’ New Era-RNA Vaccine

Zhou, W., Jiang, L., Liao, S., Wu, F., Yang, G., Hou, L., Liu, L., Pan, X., Jia, W. W.-G., & Zhang, Y. (2023) · Viruses · doi:10.3390/v15081760 · Cited by 64

Widespread exposure to SARS-CoV-2 in wildlife communities

Goldberg, A. R., Langwig, K. E., Brown, K. L., Marano, J. M., Rai, P., King, K. M., Sharp, A. K., Ceci, A., Kailing, C. D., Kailing, M. J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49891-w · Cited by 61

SARS-CoV-2 evolution from the BA.2.86 to JN.1 variants: unexpected consequences

Wang, X., Lu, L., & Jiang, S. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.01.003 · Cited by 51

Editorial: A Rapid Global Increase in COVID-19 is Due to the Emergence of the EG.5 (Eris) Subvariant of Omicron SARS-CoV-2

Parums, D. V. (2023) · Medical Science Monitor · doi:10.12659/msm.942244 · Cited by 51

Molecular insights into the adaptive evolution of SARS-CoV-2 spike protein

Yao, Z., Zhang, L., Duan, Y., Tang, X., & Lü, J. (2024) · Journal of Infection · doi:10.1016/j.jinf.2024.106121 · Cited by 49

A protein language model for exploring viral fitness landscapes

Ito, J., Strange, A. P., Liu, W., Joas, G., Lytras, S., Matsuno, K., Nao, N., Sawa, H., Mizuma, K., Kojima, I., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59422-w · Cited by 51

Chronic inflammation in post-acute sequelae of COVID-19 modulates gut microbiome: a review of literature on COVID-19 sequelae and gut dysbiosis

Iqbal, N. T., Khan, H., Khalid, A., Mahmood, S. F., Nasir, N., Khanum, I., de Siqueira, I. C., & Voorhis, W. C. V. (2025) · Molecular Medicine · doi:10.1186/s10020-024-00986-6 · Cited by 49

Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients

Standing, J. F., Buggiotti, L., Guerra‐Assunção, J. A., Woodall, M. N. J., Ellis, S., Agyeman, A. A., Miller, C. M., Okechukwu, M., Kirkpatrick, E., Jacobs, A. I., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45641-0 · Cited by 42

SARS-CoV-2-associated lymphopenia: possible mechanisms and the role of CD147

Shouman, S., Elkholy, N., Hussien, A. E., El-Derby, A. M., Magdy, S., Abou‐Shanab, A. M., Elmehrath, A. O., Abdelwaly, A., Helal, M. A., & El‐Badri, N. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01718-3 · Cited by 47

SARS-CoV-2 correlates of protection from infection against variants of concern

Sun, K., Bhiman, J. N., Tempia, S., Kleynhans, J., Madzorera, V. S., Mkhize, Q., Kaldine, H., McMorrow, M., Wolter, N., Moyes, J., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03131-2 · Cited by 45

Evolution and implications of SARS-CoV-2 variants in the post-pandemic era

Manirambona, E., Okesanya, O. J., Olaleke, N. O., Oso, T. A., & Lucero‐Prisno, D. E. (2024) · Discover Public Health · doi:10.1186/s12982-024-00140-x · Cited by 41

Intra- vs. Interhost Evolution of SARS-CoV-2 Driven by Uncorrelated Selection—The Evolution Thwarted

Hou, M., Shi, J., Gong, Z., Wen, H., Lan, Y., Deng, X., Fan, Q., Li, J. J., Jiang, M., Tang, X., et al. (2023) · Molecular Biology and Evolution · doi:10.1093/molbev/msad204 · Cited by 35

Epidemic history and evolution of an emerging threat of international concern, the severe acute respiratory syndrome coronavirus 2

Giovanetti, M., Branda, F., Cella, E., Scarpa, F., Bazzani, L., Ciccozzi, A., Slavov, S. N., Benvenuto, D., Sanna, D., Casu, M., et al. (2023) · Journal of Medical Virology · doi:10.1002/jmv.29012 · Cited by 39

SARS-CoV-2 evolution during prolonged infection in immunocompromised patients

Marques, A. D., Graham-Wooten, J., Fitzgerald, A. S., Leonard, A. S., Cook, E. J., Everett, J. K., Rodino, K. G., Moncla, L. H., Kelly, B. J., Collman, R. G., et al. (2024) · mBio · doi:10.1128/mbio.00110-24 · Cited by 35

Demultiplexing and barcode-specific adaptive sampling for nanopore direct RNA sequencing

van der Toorn, W., Bohn, P. S., Liu-Wei, W., Olguin-Nava, M., Gribling-Burrer, A.-S., Smyth, R. P., & von Kleist, M. (2025) · Nature Communications · doi:10.1038/s41467-025-59102-9 · Cited by 33

COVID-19 annual update: a narrative review

Biancolella, M., Colona, V. L., Luzzatto, L., Watt, J. L., Mattiuz, G., Conticello, S. G., Kaminski, N., Mehrian‐Shai, R., Ko, A. I., Gonsalves, G., et al. (2023) · Human Genomics · doi:10.1186/s40246-023-00515-2 · Cited by 33

Long COVID across SARS-CoV-2 variants, lineages, and sublineages

Padilla, S., Ledesma, C., García‐Abellán, J., García, J. A., Fernández‐González, M., de la Rica, A., Galiana, A., Gutiérrez, F., & Masiá, M. (2024) · iScience · doi:10.1016/j.isci.2024.109536 · Cited by 31

Key Considerations during the Transition from the Acute Phase of the COVID-19 Pandemic: A Narrative Review

Rzymski, P., Pokorska‐Śpiewak, M., Jackowska, T., Kuchar, E. P., Nitsch-Osuch, A. S., Pawłowska, M., Babicki, M., Jaroszewicz, J., Szenborn, L., Wysocki, J., et al. (2023) · Vaccines · doi:10.3390/vaccines11091502 · Cited by 31

Main and papain-like proteases as prospective targets for pharmacological treatment of coronavirus SARS-CoV-2

Yevsieieva, L. V., Lohachova, K. O., Kyrychenko, A. V., Kovalenko, S. М., Ivanov, V. V., & Kalugin, O. N. (2023) · RSC Advances · doi:10.1039/d3ra06479d · Cited by 38

Alteration of prostaglandin production and agonist responsiveness by n-6 polyunsaturated fatty acids in endometrial cells from late-gestation ewes

Cheng, Z., Elmes, M. J., Kirkup, S. E., Abayasekara, D. R. E., & Wathes, D. C. (2004) · Journal of Endocrinology · doi:10.1677/joe.0.1820249 · Cited by 31

Role of SARS-CoV-2 mutations in the evolution of the COVID-19 pandemic

Colson, P., Chaudet, H., Delerce, J., Pontarotti, P., Levasseur, A., Fantini, J., Scola, B. L., Devaux, C. A., & Raoult, D. (2024) · Journal of Infection · doi:10.1016/j.jinf.2024.106150 · Cited by 33

Optical biosensors for diagnosis of COVID-19: nanomaterial-enabled particle strategies for post pandemic era

Tekin, Y. Ş., Kul, S. M., Sağdıç, O., Rodthongkum, N., Geiss, B. J., & Özer, T. (2024) · Microchimica Acta · doi:10.1007/s00604-024-06373-6 · Cited by 30

Chasing SARS-CoV-2 XBB.1.16 Recombinant Lineage in India and the Clinical Profile of XBB.1.16 Cases in Maharashtra, India

Karyakarte, R. P., Das, R., Rajmane, M. V., Dudhate, S., Agarasen, J., Pillai, P., Chandankhede, P. M., Labhshetwar, R. S., Gadiyal, Y., Kulkarni, P. P., et al. (2023) · Cureus · doi:10.7759/cureus.39816 · Cited by 30

A safe, effective and adaptable live-attenuated SARS-CoV-2 vaccine to reduce disease and transmission using one-to-stop genome modifications

Schön, J., Barut, G. T., Trüeb, B. S., Halwe, N. J., Veiga, I. B., Kratzel, A., Ulrich, L., Kelly, J. N., Brügger, M., Wylezich, C., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01755-1 · Cited by 32

Progress in Research on Inhibitors Targeting SARS-CoV-2 Main Protease (M pro )

Yang, Y., Luo, Y., Zhang, C., Xiang, Y., Bai, X., Zhang, D., Fu, Z., Hao, R.-B., & Liu, X. (2024) · ACS Omega · doi:10.1021/acsomega.4c03023 · Cited by 34

One-pot synthesized Au@Pt nanostars-based lateral flow immunoassay for colorimetric and photothermal dual-mode detection of SARS-CoV-2 nucleocapsid antibody

Zhu, J., Guo, G., Liu, J., Li, X., Yang, X., Liu, M., Fu, C., Zeng, J., & Li, J. (2024) · Analytica Chimica Acta · doi:10.1016/j.aca.2024.342241 · Cited by 29

Diclofenac, ibuprofen, and paracetamol biodegradation: overconsumed non-steroidal anti-inflammatories drugs at COVID-19 pandemic

Ferreira, B. L., Ferreira, D. P., Borges, S. F., Ferreira, A. M., Holanda, F. H., Ucella-Filho, J. G. M., Cruz, R. A. S., Birolli, W. G., Luque, R., & Ferreira, I. M. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1207664 · Cited by 28

Structural and molecular basis of the epistasis effect in enhanced affinity between SARS-CoV-2 KP.3 and ACE2

Feng, L., Sun, Z., Zhang, Y., Jian, F., Yang, S., Xia, K., Yu, L., Wang, J., Shao, F., Wang, X., et al. (2024) · Cell Discovery · doi:10.1038/s41421-024-00752-2 · Cited by 27

Polyvalent Nanobody Structure Designed for Boosting SARS-CoV-2 Inhibition

Song, T., Cooper, L. M., Achi, J. G., Wang, X., Dwivedy, A., Rong, L., & Wang, X. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.3c11760 · Cited by 25

An immunostimulatory glycolipid that blocks SARS-CoV-2, RSV, and influenza infections in vivo

Tsuji, M., Nair, M. S., Masuda, K., Castagna, C., Chong, Z., Darling, T. L., Seehra, K., Hwang, Y., Ribeiro, Á. L., Ferreira, G. M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39738-1 · Cited by 25

Lineage replacement and evolution captured by 3 years of the United Kingdom Coronavirus (COVID-19) Infection Survey

Lythgoe, K., Golubchik, T., Hall, M. D., House, T., Cahuantzi, R., MacIntyre-Cockett, G., Fryer, H. R., Thomson, L., Nurtay, A., Ghafari, M., et al. (2023) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2023.1284 · Cited by 28

The plasticity of immune memory in invertebrates

Lanz‐Mendoza, H., Gálvez, D., & Contreras-Garduño, J. A. (2024) · Journal of Experimental Biology · doi:10.1242/jeb.246158 · Cited by 24

A unified evolution-driven deep learning framework for virus variation driver prediction

Nie, Z., Liu, X., Chen, J., Wang, Z., Liu, Y., Si, H.-R., Dong, T., Xu, F., Song, G., Wang, Y., et al. (2025) · Nature Machine Intelligence · doi:10.1038/s42256-024-00966-9 · Cited by 25

An inoculation site-retained mRNA vaccine induces robust immune responses against SARS-CoV-2 variants

Huang, L., Zhao, F., He, M., Fang, Y., Ma, X., Lu, S., Li, E., Xiao, H. Q., Zhu, H., Wang, X., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.01.002 · Cited by 23

Chaos theory in the understanding of COVID-19 pandemic dynamics

Calistri, A., Roggero, P. F., & Palù, G. (2024) · Gene · doi:10.1016/j.gene.2024.148334 · Cited by 22

Non-Covalent Inhibitors of SARS-CoV-2 Papain-Like Protease (PLpro): In Vitro and In Vivo Antiviral Activity

Reddy, V. G., Shen, Z., Holberg, C., Fu, J., Soleymani, F., Cooper, L. M., Ramos, O. L., Indukuri, D. R., Musku, S. R., Rychetsky, P., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00378 · Cited by 22

Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19: an international, randomised, open-label trial

Hoffmann, S., Schrezenmeier, E. V., Desmarets, M., Halleck, F., Dürrbach, A., Peters, L., Tremmel, A.-T., Seidel, A., Führer, M., Bachmann, F., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105613 · Cited by 22

COV2Var, a function annotation database of SARS-CoV-2 genetic variation

Feng, Y., Yi, J., Yang, L., Wang, Y., Wen, J., Zhao, W., Kim, P., & Zhou, X. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad958 · Cited by 26

Molecular and structural insights into SARS-CoV-2 evolution: from BA.2 to XBB subvariants

Yajima, H., Nomai, T., Okumura, K., Maenaka, K., Ito, J., Hashiguchi, T., Sato, K., Matsuno, K., Nao, N., Sawa, H., et al. (2024) · mBio · doi:10.1128/mbio.03220-23 · Cited by 23

Persisting Shadows: Unraveling the Impact of Long COVID-19 on Respiratory, Cardiovascular, and Nervous Systems

Sideratou, C.-M., & Papaneophytou, C. P. (2023) · Infectious Disease Reports · doi:10.3390/idr15060072 · Cited by 23

Global spread of COVID-19's JN.1 variant: Implications and public health responses

Satapathy, P., Kumar, P., Mehta, V., Suresh, V., Khare, A., Rustagi, S., Daulati, M. N., Neyazi, M., Najafi, E., & Neyazi, A. (2024) · New Microbes and New Infections · doi:10.1016/j.nmni.2024.101225 · Cited by 21

Severity of respiratory syncytial virus compared with SARS-CoV-2 and influenza among hospitalised adults ≥65 years

Vega‐Piris, L., Carretero, S. G., Mayordomo, J. L., Zarzuelo, M. R., Río, V. Á., García, V. G., García‐Vázquez, M., Rodríguez, M. D. C. G., Basile, L., González‐Coviella, N. L., et al. (2024) · Journal of Infection · doi:10.1016/j.jinf.2024.106292 · Cited by 20

GII.17 norovirus re-emerged in the 2020s as a result of dynamic and adaptive evolutionary processes

Tohma, K., Jacobsen, S., Altmann, B., Kendra, J. A., Landivar, M., O, W. E. D. L., Fernández-García, M. D., Gomes, K. A., Chudnovsky, S., Ford-Siltz, L. A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66279-6 · Cited by 20

Mutational signature dynamics indicate SARS-CoV-2’s evolutionary capacity is driven by host antiviral molecules

Lamb, K. D., Luka, M. M., Saathoff, M., Orton, R. J., Phan, M. V. T., Cotten, M. L., Yuan, K., & Robertson, D. L. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011795 · Cited by 26

Neuroinvasion and neurotropism of severe acute respiratory syndrome coronavirus 2 infection

Jagst, M., Pottkämper, L., Gömer, A., Pitarokoili, K., & Steinmann, E. (2024) · Current Opinion in Microbiology · doi:10.1016/j.mib.2024.102474 · Cited by 21

Comprehensive Overview of Broadly Neutralizing Antibodies against SARS-CoV-2 Variants

Cui, L., Li, T., Xue, W., Zhang, S., Wang, H., Liu, H., Gu, Y., Xia, N., & Li, S. (2024) · Viruses · doi:10.3390/v16060900 · Cited by 18

Durability of immunity and clinical protection in nursing home residents following bivalent SARS-CoV-2 vaccination

Gravenstein, S., DeVone, F., Oyebanji, O. A., Abul, Y., Cao, Y., Chan, P. A., Halladay, C. W., Rudolph, J. L., Nugent, C., Bosch, J., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105180 · Cited by 19

Long-term increase in soluble interleukin-6 receptor levels in convalescents after mild COVID-19 infection

Lokau, J., Garbers, Y., Vicente, M. M., Dittrich, A., Meltendorf, S., Lingel, H., Münster-Kühnel, A. K., Brunner-Weinzierl, M. C., & Garbers, C. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1488745 · Cited by 20

Impact of mutations defining SARS-CoV-2 Omicron subvariants BA.2.12.1 and BA.4/5 on Spike function and neutralization

Pastorio, C., Noettger, S., Nchioua, R., Zech, F., Sparrer, K. M. J., & Kirchhoff, F. (2023) · iScience · doi:10.1016/j.isci.2023.108299 · Cited by 22

The emergence and implications of SARS-CoV-2 omicron subvariant BA.2.86 on global health

Satapathy, P., Kumar, P., Gupta, J. K., Rabaan, A. A., Kaabi, N. A. M. A., Mohanty, D., Pathakala, N., Khatib, M. N., Gaidhane, S., Zahiruddin, Q. S., et al. (2024) · International Journal of Surgery · doi:10.1097/js9.0000000000001070 · Cited by 19

Drivers of epidemic dynamics in real time from daily digital COVID-19 measurements

Kendall, M., Luca Ferretti, A., Wymant, C., Tsallis, D., Petrie, J., Francia, A. D., Lauro, F. D., Abeler‐Dörner, L., Manley, H., Panovska‐Griffiths, J., et al. (2024) · Science · doi:10.1126/science.adm8103 · Cited by 19

SARS-CoV-2: The Interplay Between Evolution and Host Immunity

Case, J. B., Jain, S., Suthar, M. S., & Diamond, M. (2024) · Annual Review of Immunology · doi:10.1146/annurev-immunol-083122-043054 · Cited by 26

Zoonosis and zooanthroponosis of emerging respiratory viruses

Khalil, A. M., Martínez‐Sobrido, L., & Mostafa, A. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1232772 · Cited by 25

Next-generation treatments: Immunotherapy and advanced therapies for COVID-19

Romero, J. A. A., Chingaté-López, S. M., Camacho, B., Alméciga-Díaz, C. J., & Ramirez-Segura, C. A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26423 · Cited by 19

Incipient functional SARS-CoV-2 diversification identified through neural network haplotype maps

Delgado, S., Somovilla, P., Ferrer‐Orta, C., Martínez‐González, B., Vázquez-Monteagudo, S., Muñoz‐Flores, J., Soria, M. E., García‐Crespo, C., de Ávila, A. I., Durán‐Pastor, A., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2317851121 · Cited by 19

Persistence of SARS‐CoV‐2 infection and viral intra ‐ and inter ‐host evolution in COVID‐19 hospitalized patients

Pavia, G., Quirino, A., Marascio, N., Veneziano, C., Longhini, F., Bruni, A., Garofalo, E., Pantanella, M., Manno, M., Gigliotti, S., et al. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29708 · Cited by 18

A decavalent composite mRNA vaccine against both influenza and COVID-19

Wang, Y., Ma, Q., Li, M., Mai, Q., Ma, L., Zhang, H., Zhong, H., Mai, K., Cheng, N., Feng, P., et al. (2024) · mBio · doi:10.1128/mbio.00668-24 · Cited by 19

Artificial intelligence with mass spectrometry-based multimodal molecular profiling methods for advancing therapeutic discovery of infectious diseases

Liu, J., Bao, C., Zhang, J., Han, Z., Fang, H., & Lu, H. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108712 · Cited by 19

C→U transition biases in SARS-CoV-2: still rampant 4 years from the start of the COVID-19 pandemic

Peter Simmonds, K. (2024) · mBio · doi:10.1128/mbio.02493-24 · Cited by 19

Impact of vaccination on SARS-CoV-2 evolution and immune escape variants

Jena, D., Ghosh, A., Jha, A., Prasad, P., & Raghav, S. K. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.07.054 · Cited by 18

A self-adjuvanted VLPs-based Covid-19 vaccine proven versatile, safe, and highly protective

Vuitika, L., Côrtes, N., Malaquias, V. B., da Silva, J. W., Lira, A. A. D. L., Prates-Syed, W. A., Schimke, L. F., Luz, D., Durães‐Carvalho, R., Balan, A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-76163-w · Cited by 20

Comparison of COVID-19 and Influenza-Related Outcomes in the United States during Fall–Winter 2022–2023: A Cross-Sectional Retrospective Study

Kopel, H., Bogdanov, A., Winer-Jones, J. P., Adams, C., Winer, I. H., Bonafede, M., Nguyễn, V. H., & Mansi, J. A. (2024) · Diseases · doi:10.3390/diseases12010016 · Cited by 17

Alterations in microbiota of patients with COVID‐19: implications for therapeutic interventions

Qiu, Y., Mo, C., Chen, L., Ye, W., Chen, G., & Zhu, T. (2024) · MedComm · doi:10.1002/mco2.513 · Cited by 18

Rapid intra-host diversification and evolution of SARS-CoV-2 in advanced HIV infection

Ko, S. H., Radecki, P. E., Belinky, F., Bhiman, J. N., Meiring, S. T., Kleynhans, J., Amoako, D. G., Canedo, V. G., Lucas, M., Kekana, D., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51539-8 · Cited by 22

Hydrogen-Bond-Induced Melem Assemblies to Resist Aggregation-Caused Quenching for Ultrasensitive ECL Detection of COVID-19 Antigen

Zhu, H.-T., Bao, J.-Y., Kang, J., Wang, A., Yuan, P.-X., & Feng, J. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c04016 · Cited by 17

Mental health in Germany before, during and after the COVID-19 pandemic

Patzina, A., Collischon, M., Hoffmann, R., & Obrizan, M. (2025) · PLoS ONE · doi:10.1371/journal.pone.0313689 · Cited by 17

mRNA-1273 vaccines adapted to JN.1 or KP.2 elicit cross-neutralizing responses against the JN.1 sublineages of SARS-CoV-2 in mice

Lee, D. W., Nasir, A., Elbashir, S. M., Jani, H., Speidel, T., Gorrie, A., Berrueta, D. M., Martin, P., Tan, S., Hou, Y. J., et al. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.126961 · Cited by 16

Predicting pathogen evolution and immune evasion in the age of artificial intelligence

Hamelin, D. J., Scicluna, M., Saadie, I., Mostefai, F., Grenier, J., Baron, C., Caron, É., & Hussin, J. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2025.03.044 · Cited by 21

Exosome‐Based Vaccines: Pioneering New Frontiers in Combating Infectious Diseases and Cancer

Wang, X., Li, A., Wang, A., He, M., Zeng, Y., Li, D., Rong, R., & Liu, J. (2025) · Small Methods · doi:10.1002/smtd.202402222 · Cited by 17

Evolutionary trajectory of SARS-CoV-2 genome shifts during widespread vaccination and emergence of Omicron variant

Gayvert, K. M., McKay, S., Lim, W. K., Baum, A., Kyratsous, C. A., Copin, R., & Atwal, G. S. (2023) · npj Viruses · doi:10.1038/s44298-023-00007-z · Cited by 17

Puzzles, challenges, and information reservoir of SARS-CoV-2 quasispecies

Domingo, E., Martínez‐González, B., García‐Crespo, C., Somovilla, P., de Ávila, A. I., Soria, M. E., Durán‐Pastor, A., & Perales, C. (2023) · Journal of Virology · doi:10.1128/jvi.01511-23 · Cited by 19

Antigenicity assessment of SARS-CoV-2 saltation variant BA.2.87.1

Yang, S., Yu, Y., Jian, F., Yisimayi, A., Song, W., Liu, J., Wang, P., Xu, Y., Wang, J., Niu, X., et al. (2024) · Emerging Microbes & Infections · doi:10.1080/22221751.2024.2343909 · Cited by 15

Phytochemicals in antiviral drug development against human respiratory viruses

Mehta, S. K., & Pradhan, R. B. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104107 · Cited by 16

A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resist

Pen, J. L., Paniccia, G., Kinast, V., Moncada‐Vélez, M., Ashbrook, A. W., Bauer, M., Hoffmann, H.-H., Pinharanda, A., Ricardo-Lax, I., Stenzel, A. F., et al. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002767 · Cited by 19

Forecasting dominance of SARS-CoV-2 lineages by anomaly detection using deep AutoEncoders

Rancati, S., Nicora, G., Prosperi, M., Bellazzi, R., Salemi, M., & Marini, S. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae535 · Cited by 16

RT-qPCR Testing and Performance Metrics in the COVID-19 Era

Bustin, S. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179326 · Cited by 16

Tissue-resident memory T cells contribute to protection against heterologous SARS-CoV-2 challenge

Odle, A. E., Kar, M., Verma, A. K., Sariol, A., Meyerholz, D. K., Suthar, M. S., Wong, L.-Y. R., & Perlman, S. M. (2024) · JCI Insight · doi:10.1172/jci.insight.184074 · Cited by 15

Receptor Binding for the Entry Mechanisms of SARS-CoV-2: Insights from the Original Strain and Emerging Variants

Mahdi, M., Kiarie, I. W., Mótyán, J. A., Hoffka, G., Al-Muffti, A. S., Tóth, A., & Tőzsér, J. (2025) · Viruses · doi:10.3390/v17050691 · Cited by 16

Ghosts of the past: Elemental composition, biosynthesis reactions and thermodynamic properties of Zeta P.2, Eta B.1.525, Theta P.3, Kappa B.1.617.1, Iota B.1.526, Lambda C.37 and Mu B.1.621 variants of SARS-CoV-2

Popovic, M. E., Pavlović, M. R. P., & Pavlović, M. M. (2023) · Microbial Risk Analysis · doi:10.1016/j.mran.2023.100263 · Cited by 15

Silent battles: immune responses in asymptomatic SARS-CoV-2 infection

Bert, N. L., & Samandari, T. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01127-z · Cited by 16

CRISPR/Cas Technology: The Unique Synthetic Biology Genome-Editing Tool Shifting the Paradigm in Viral Diagnostics, Defense, and Therapeutics

Zhou, L., & Simonian, A. L. (2024) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-081723-013033 · Cited by 18

Deciphering Fc-effector functions against SARS-CoV-2

Beaudoin-Bussières, G., & Finzi, A. (2024) · Trends in Microbiology · doi:10.1016/j.tim.2024.01.005 · Cited by 19

Zoonotic Origin, Genomic Organization, Transmission, and Mutation of SARS-CoV-2

Singh, A., Fazal, R., Sahu, U., Kumar, M., Bhatia, S., Sanyal, A., & Kumar, N. (2024) · Apple Academic Press eBooks · doi:10.1201/9781003467939-1

Five years of SARS-CoV-2 evolution: variants, mechanisms, and public health challenges

Aranda-Abreu, G. E., Rojas-Durán, F., Hernández‐Aguilar, M. E., Herrera‐Covarrubias, D., Tlapa-Monge, L. R., Pérez-Estudillo, C. A., Borra, A. C., & Mestizo-Gutiérrez, S. L. (2026) · Future Virology · doi:10.1080/17460794.2026.2674487

On the evolution of SARS-CoV-2 and the emergence of variants of concern

Magiorkinis, G. (2022) · Trends in Microbiology · doi:10.1016/j.tim.2022.10.008 · Cited by 25

Evolutionary Mechanisms of the Emergence of the Variants of Concern of SARS-CoV-2

Rouzine, I. M. (2025) · Viruses · doi:10.3390/v17020197 · Cited by 12

Investigating the evolutionary origins of the first three SARS-CoV-2 variants of concern

Ghafari, M., Liu, Q., Dhillon, A., Katzourakis, A., & Weissman, D. B. (2022) · Frontiers in Virology · doi:10.3389/fviro.2022.942555 · Cited by 35